On cfDNA in hematologic cancers: A Q&A with Dr. Mark Murakami
Dr. Murakami discusses the molecular tools enabling the pursuit of precision medicine
Dr. Murakami discusses the molecular tools enabling the pursuit of precision medicine
Technology advances, coupled with collaborations between equipment makers and healthcare organizations, are improving early detection of blood cancers in Africa
Validated drug discovery assay overcomes previous challenges in targeting NaV1.9 ion channels for chronic pain signalling
The VENTANA TROP2 (EPR20043) RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment
Grifols and IBL, a Tecan company, seek to revolutionize clinical diagnostics with a future high-sensitivity, multiplexed immunoassay platform
Breakthrough status provides expedited review and closer collaboration with the FDA, ultimately enabling broader market reach and commercial adoption